Surging Prevalence of Gastrointestinal Cancers and Advancements in Therapeutic Endoscopy Fuel a Steady 5.51% CAGR in the Global ESD Landscape.Austin, United States, April 07, 2026 (GLOBE NEWSWIRE) -- ...

Background: Endoscopic mucosal resection is an established method for treating intramucosal gastric neoplasms. Conventional endoscopic mucosal resection has predominantly been performed using strip ...

Additionally, the publication of clinical guidelines by leading gastroenterological societies in Western countries has legitimized the use of ESD for treating early-stage gastric, esophageal, and ...

Background and Aim: Gastrointestinal stromal tumors (GISTs), the most common mesenchymal tumors of the digestive tract with potential for malignant transformation, are mainly treated by open surgery ...

Subgroup analysis of JCOG0501 phase III study to confirm superiority of additional neoadjuvant chemotherapy with S-1 plus cisplatin to D2 gastrectomy with S-1 adjuvant chemotherapy for resectable type ...

Please provide your email address to receive an email when new articles are posted on . CHARLOTTE, N.C. — Same-day discharge is a safe and feasible option for patients who undergo endoscopic ...

A prospective clinical trial from researchers in Japan shows magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer to be a feasible and safe method in humans.

Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic CRC: Analysis of patients treated within the PanaMa trial (AIO KRK 0212). Panitumumab ...

Endoscopic submucosal dissection (ESD) of large colorectal adenomas resulted in a lower recurrence rate compared with endoscopic mucosal resection (EMR), but the more technically complex ESD had a ...

DELRAY BEACH, Fla., Aug. 27, 2025 /PRNewswire/ -- The global Endoscopic Submucosal Dissection Market, valued at US$0.46 billion in 2024, stood at US$0.50 billion in 2025 and is projected to advance at ...